Olympic Sprinter Beth Dobbin's Battle With ME: From Tokyo Games to 22 Hours in Bed Daily

From Elite Athlete to Severe Illness

Beth Dobbin, who represented Great Britain as a sprinter at the 2021 Tokyo Olympics, now spends more than 22 hours each day confined to bed at age 32. Five years after competing at the Games, she has been diagnosed with myalgic encephalomyelitis (ME), a chronic illness that has systematically dismantled her athletic career, independence, and quality of life. Her willingness to discuss her condition publicly comes at considerable personal risk—she acknowledges that even a 30-minute interview could trigger a severe health deterioration lasting months.

The Onset and Medical Puzzle

Dobbin's decline began in winter 2021-22 following back-to-back infections with Covid and glandular fever, both discovered only through retrospective testing despite initial mild symptoms. Initially, she dismissed the warning signs: slightly elevated sleep needs and marginally slower running times. As she progressed through an unusually compressed competitive season that year, her symptoms escalated dramatically. At the World Championships, she battled painful throat inflammation and disrupted sleep. During the Commonwealth Games, dizziness plagued her runs. At the European Championships, she false-started after losing all sensation in her legs while in the starting blocks—a moment she later described as her year of hell.

After the European Championships, she rested extensively, but symptoms only intensified. When she attempted to resume training after six weeks, she managed just three weeks before her condition worsened further. Multiple specialists across different medical domains eventually reached the same diagnosis: ME. Doctors expressed reluctance about this conclusion, acknowledging the absence of effective treatments or cures.

Understanding ME: A Misnamed Condition

ME, also called chronic fatigue syndrome, affects an estimated 400,000 people in the UK, though the true figure may exceed one million. The condition produces more than 200 potential symptoms, including nausea, headaches, cognitive dysfunction, brain fog, sleep disturbances, memory problems, pain, and severe persistent fatigue unrelieved by rest. Dobbin strongly objects to the chronic fatigue syndrome label, arguing it catastrophically understates the illness's severity. Drawing on her lifetime as a disciplined athlete who once balanced eight-hour work shifts with professional training, she contends that fatigue represents perhaps the twentieth most debilitating symptom she experiences. The condition feels instead like her entire body is shutting down, creating a sensation of approaching death.

A single conversation, or even minimal sensory input like excessive brightness or noise, can trigger a crash lasting 24 hours, 48 hours, or potentially months. Dobbin currently leaves her house roughly five times annually. She often remains too unwell to sleep despite spending nearly all her time in bed, requiring medication to achieve rest. Even sitting upright for extended periods exhausts her reserves, so she remains propped in bed—a position that reduces symptom severity without eliminating them.

The Medical System's Failure

The NHS provides no specialist ME service, and Dobbin has found herself educating general practitioners about her own condition. After her British Athletics funding ended, she waited 22 months for a face-to-face appointment with a private specialist she had to source independently. Her parents and sister describe the helplessness of witnessing her decline with no viable interventions. Her father Jim, a former footballer with Barnsley, Grimsby, and Doncaster Rovers, expresses desperation to help but confronts the reality that nothing exists to offer. Her mother Jean describes waking each day consumed by sadness and worry about Beth's future care, noting that GPs have nowhere to refer patients and that ME research remains chronically underfunded and deprioritized.

A Platform for Advocacy

Despite the personal cost, Dobbin has chosen to speak publicly, recognizing that her athlete status grants her credibility that many ME patients lack. She notes that people with ME often report being disbelieved and labeled as lazy, but her athletic background prevents such dismissals. Her sister Faye is running the Yorkshire Marathon to raise funds for ME Research UK, describing the situation as akin to grief—constant worry about Beth's trajectory and whether she will improve, deteriorate, or contract another triggering illness.

Dobbin acknowledges her outlook is bleak but finds modest hope in heightened medical attention following the Covid pandemic and the emergence of long Covid, which shares significant symptom overlap with ME. Since Covid emerged, research funding and medical interest have surged. She expresses cautious optimism that effective treatments may eventually emerge, though she recognizes this offers limited solace to her present suffering. Speaking out, she believes, fulfills a duty given her platform and visibility—awareness she hopes will ultimately benefit the broader ME community who lack her voice.